Analyst Ratings for Iterum Therapeutics (ITRM) [Buys]

ITRM Rating Summary

  |   Expand Research on ITRM
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 28%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/19/2018 Needham & Company
» Updated 3/13/2020
Alan L. Carr New Coverage Buy
(N/A)
7.00
(20.00)
12.00
(0.53)
-95.58% Details
6/19/2018 Guggenheim N/A New Coverage Buy
(N/A)
21.00
(N/A)
12.00
(0.53)
-95.58% Details
Like ITRM Ratings? Also take a look at PLL, SCYX, SMMT, QFIN

ITRM Ratings News